Due to recent changes in the official account push mechanism, we welcome you to set Boom Health as a "starred" account on the homepage of the official account to get the latest trends and expert insights in the digital healthcare industry第一时间!
01 Global Digital Health Investment and Financing OverviewInnovative Health Insurance Provider Sidecar Health Raises $165 Million in Series D FundingOn June 26, Sidecar Health, an innovative health insurance plan provider, secured $165 million in Series D funding, led by Koch Disruptive Technologies. Sidecar Health is transforming the system through a model that offers a first-of-its-kind free-market healthcare approach, empowering consumers rather than insurance companies to take control of their care decisions with unprecedented tools, transparency, and fewer restrictions.AI Drug Discovery Platform EvolutionaryScale Secures $142 Million in Seed FundingOn June 25, AI drug discovery platform EvolutionaryScale secured $142 million in seed funding. This round was led by former GitHub CEO Nat Friedman, Daniel Gross, and Lux Capital, with participation from Amazon and Nvidia's corporate venture capital arm, NVentures. The funds will be used to build artificial intelligence models to generate new proteins for scientific research.AI Drug Delivery Platform METiS TechBio Completes $100 Million Series C FinancingOn June 21, METiS TechBio, an AI drug delivery platform, completed its $100 million Series C financing. This round was led by a fund under CICC Capital, with participation from Taiping Hong Kong Insurance Technology Innovation Fund under China Taiping. METiS TechBio has raised nearly $300 million in total funding to date. The proceeds from this round will primarily be used to further advance the development of the AI + drug delivery platform and the company’s proprietary pipeline, supporting METiS TechBio's continued innovation in the field of drug delivery.Intelligent Implantable Solutions Provider UroMems Secures $47 Million in Series C FinancingOn June 25, UroMems, a provider of smart implantable solutions, secured $47 million in Series C funding led by Crédit Mutuel Innovation. The funds will support large-scale pivotal clinical trials of the UroActive™ implant in the United States and Europe, paving the way for regulatory submissions in multiple countries. UroActive is the first smart automatic artificial urinary sphincter product designed for the treatment of SUI.Virtual Medical Service Provider Pomelo Care Secures $46 Million in Series B FundingOn June 20, virtual medical service provider Pomelo Care secured a $46 million Series B financing round. The round was led by existing investors First Round Capital and Andreessen Horowitz (a16z) Bio+Health, with participation from Stripes, SV Angel, Operator Partners, and BoxGroup. Pomelo will use the funds to accelerate its partnerships with payers across China to address the root causes of the maternal health crisis.CollectAdonis, an Intelligent and Automation Platform, Secures $31 Million in Series B FundingOn June 25, Adonis, a revenue intelligence and automation platform, secured $31 million in Series B funding led by Point72 Private Investments. Adonis collaborates with over 10,000 suppliers, handling tens of millions of claims with fees totaling more than $13.3 billion. The new round of financing will be used to accelerate product innovation, continue expansion into the healthcare systems sector, and grow the team.Prior Authorization Submission Service Platform Humata Health Raises $25 Million in FinancingOn June 20, prior authorization submission service platform Humata Health secured $25 million in funding. This round was led by Blue Venture Fund and LRVHealth. With this funding, the company will expand the scope of its proprietary generative artificial intelligence technology, grow its customer base with leading healthcare providers across China, and begin collaborating with payers and delegated entities to offer complementary solutions to help streamline prior authorization.Digital Life Insurance Platform Amplify Life Insurance Secures $20 Million in Series B FundingOn June 24, digital life insurance platform Amplify Life Insurance secured $20 million in Series B funding, co-led by Crosslink Capital and Anthemis. Amplify Life Insurance is a leading digital platform offering AI-powered educational journeys, product recommendations and quotes, and real-time pre-underwriting to help customers understand plans and customize policies according to their needs.Proteomics Platform Frontier Medicines Completes $20 Million Series C Extension FinancingOn June 25, proteomics platform Frontier Medicines completed a $20 million extension of its Series C financing, bringing the total amount raised to $100 million, with investors including Deep Track Capital and ArrowMark Partners. The proceeds will support the further development of Frontier's FMC-376, as well as other preclinical/pipeline programs targeting high-value precision medicine targets.Virtual Care Platform Heyday Health Raises $12.5 Million in New Round of FinancingOn June 24, virtual care platform Heyday Health secured $12.5 million in a new round of financing, with investors including Gradient Ventures, Lionbird, Great Oaks Capital, and others. The funds will drive Heyday's business expansion into new regions, providing high-quality and convenient care for patients covered by Medicare and those with dual eligibility, enabling them to receive care at home.Health and Fitness Platform Zing Coach Raises $10 Million in Series A FundingOn June 21, health and fitness platform Zing Coach secured $10 million in Series A funding, led by Zubr Capital and Triple Point Capital. The funds will be used to expand Zing Coach's development team, enhance marketing efforts, and enter new international markets. Additionally, the company will further refine its AI Coach technology. Following the full launch, the company plans to utilize its AI Coaching technology for other forms of exercise, such as Pilates and yoga.Dental Revenue Cycle Management Platform Zuub Raises $9 Million in Series A FundingOn June 25, Zuub, a dental revenue cycle management platform, secured $9 million in Series A funding, led by Vertical Venture Partners, with participation from existing investors Bonfire Ventures and MTech Capital. This significant investment will further advance Zuub's mission to address billions of dollars in revenue loss within the dental industry by leveraging artificial intelligence and advanced automation technologies.AI-Assisted Diagnosis Product Developer Qure.ai Receives Strategic InvestmentOn June 25, Qure.ai, a developer of AI-assisted diagnostic products, received strategic investment from Merck GHI Fund. Qure.ai has established significant operations, deploying artificial intelligence solutions for tuberculosis (TB), lung cancer, and stroke detection across more than 2,700 imaging facilities in over 90 countries. This strategic investment will drive the expansion of global access to AI imaging technology.02 Digital Health Industry DynamicsRoche Collaborates with Ascidian on RNA Editing TherapyOn June 18, biotechnology company Ascidian Therapeutics announced a collaboration with Roche to jointly discover and develop RNA exon editing therapies for neurological diseases. Under the agreement, Ascidian will receive an upfront payment of $42 million and is eligible for up to $1.8 billion in research, clinical, and commercial milestone payments, as well as royalties on global commercial sales.Belharra Therapeutics Partners with Sanofi to Advance Development of Novel Small-Molecule Immunology TreatmentsOn June 18, to further strengthen its commitment to immunology and inflammation research, Sanofi partnered with Belharra Therapeutics and its chemoproteomics platform to develop small molecules targeting disease-related pathways, which will be selected by Sanofi. The California-based biotech company will receive up to $40 million in upfront and near-term milestone payments. Belharra is also eligible for up to $700 million in research, development, and commercial milestone payments, as well as tiered royalties.Day One Biopharmaceuticals Reaches Exclusive Licensing Agreement with MabCare TherapeuticsOn June 18, clinical-stage biopharmaceutical company Day One Biopharmaceuticals announced an exclusive licensing agreement with MabCare Therapeutics for MTX-13, an innovative PTK7 ADC drug, in a deal worth up to $1.2 billion. Day One has made an upfront payment of $55 million to acquire all rights to MTX-13 outside Greater China. Additionally, MabCare is eligible to receive up to $1.152 billion in development, regulatory, and commercial success milestone payments.03 Overview of Global Digital Health M&APrivate Equity Firm Altaris Plans $518 Million Acquisition of SharecareOn June 24, digital healthcare company Sharecare agreed to be acquired by private equity firm Altaris for $1.43 per share in cash (approximately $518 million). Altaris plans to take Sharecare private upon completion of the transaction. Sharecare offers a comprehensive data-driven virtual health platform designed to help people manage all their health needs in one place.Risant Health Signs Definitive Agreement to Acquire Cone HealthOn June 21, Risant Health, a subsidiary of Kaiser Permanente, signed a definitive agreement to acquire Cone Health. The financial terms and potential timeline of the transaction have not been disclosed. According to the agreement, Cone Health will become part of Risant Health. This transaction is subject to regulatory approval, and if completed, Cone Health will continue to independently operate its five-hospital healthcare system and insurance division.Artery Network/Arterial Orange Industry Think Tank/China Renaissance/BGI Co-Win/Rock Health/Mobile Health News/Fierce Health, etc.
Compiled by: Zhang Qiankun
